Norway’s royal household announced Wednesday that Crown Princess Mette-Marit has successfully undergone a lung transplant and is now recuperating.
The breakthrough procedure marks a critical turning point in her years-long battle with pulmonary fibrosis, a life-threatening condition that scarred her lungs and made breathing increasingly difficult.
The 52-year-old princess was first diagnosed with pulmonary fibrosis in 2018, an incurable disease that stiffens lung tissue.
Her health deteriorated more rapidly than expected, prompting doctors to place her on the transplant waiting list in early June after determining a double lung transplant was essential.
What distinguishes this moment is not just the surgical success but the profound human cost already paid by the royal family.
Crown Prince Haakon has dramatically cut his official workload to remain beside his gravely ill wife, signaling that Norway’s future monarchy faces an uncertain transition period depending on her recovery.
Dr. Are Martin Holm, the lung specialist managing her treatment at Oslo University Hospital, described her condition as serious before the operation.
Medical teams emphasized that finding a compatible donor was critical, and the successful transplant represents a rare victory against a disease that previously gave her only approximately one year without surgery.
The princess shared her own perspective in a previous interview with NRK, stating her health had worsened “more rapidly than I had hoped.”
Her public transparency about pulmonary fibrosis has already raised awareness about organ donation needs in Norway.
Norway now watches closely as the crown princess enters her recovery phase. The royal house will provide updates on her progress while the nation reflects on how this health crisis reshapes expectations for the monarchy’s next generation.
Also Read | Roberto Martinez Leaves Portugal After 2026 World Cup
